- Home
- HG vs BHC Comparison
HG vs BHC Comparison
Compare HG & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HG | BHC |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Bermuda | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 2023 | 1996 |
Fundamental Metrics
Financial Performance| Metric | HG | BHC |
|---|---|---|
| Price | $28.65 | $5.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $31.25 | $8.33 |
| AVG Volume (30 Days) | 415.4K | ★ 2.1M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 6.84% | N/A |
| EPS Growth | 51.23 | ★ 423.08 |
| EPS | ★ 5.55 | 0.42 |
| Revenue | $2,905,524,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $1.87 | $4.48 |
| Revenue Next Year | $12.41 | N/A |
| P/E Ratio | ★ $5.27 | $12.19 |
| Revenue Growth | ★ 24.70 | N/A |
| 52 Week Low | $16.80 | $4.28 |
| 52 Week High | $32.21 | $8.69 |
Technical Indicators
Market Signals| Indicator | HG | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 44.19 | 35.56 |
| Support Level | $28.06 | $4.93 |
| Resistance Level | $28.71 | $7.22 |
| Average True Range (ATR) | 0.65 | 0.17 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 38.72 | 14.42 |
Price Performance
Historical ComparisonAbout HG Hamilton Insurance Group Ltd. Class B
Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.